Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
17.9M
-
Shares change
-
+1.44M
-
Total reported value, excl. options
-
$144M
-
Value change
-
+$9.89M
-
Number of buys
-
46
-
Number of sells
-
-17
-
Price
-
$8.00
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q2 2016
72 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q2 2016.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.9M shares
of 51.1M outstanding shares and own 35.03% of the company stock.
Largest 10 shareholders include BROOKSIDE CAPITAL MANAGEMENT LLC (1.93M shares), FMR LLC (1.92M shares), DEERFIELD MANAGEMENT CO (1.17M shares), PERCEPTIVE ADVISORS LLC (1.1M shares), VHCP Management II, LLC (1M shares), Vivo Capital, LLC (990K shares), PRICE T ROWE ASSOCIATES INC /MD/ (969K shares), FRANKLIN RESOURCES INC (701K shares), BlackRock Advisors LLC (688K shares), and VANGUARD GROUP INC (570K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.